Clinical Trial Update: Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating gene expression after GnRH agonist trigger of oocyte maturation; terminated with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Receptivity
• Ovarian Hyperstimulation Syndrome

Snippet

Sponsor: UConn Health | Conditions: Endometrial Receptivity, Ovarian Hyperstimulation Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2018-11-21